- Home
- RCKT vs PRG Comparison
RCKT vs PRG Comparison
Compare RCKT & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | PRG |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.2M | 1.6B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RCKT | PRG |
|---|---|---|
| Price | $3.39 | $36.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | $29.73 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.3M | 447.2K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | ★ 26.37 | N/A |
| EPS | 0.66 | ★ 1.80 |
| Revenue | N/A | ★ $2,409,223,000.00 |
| Revenue This Year | N/A | $23.77 |
| Revenue Next Year | $64.28 | $7.91 |
| P/E Ratio | ★ $5.08 | $20.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.53 | $25.80 |
| 52 Week High | $5.45 | $47.73 |
Technical Indicators
Market Signals| Indicator | RCKT | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 45.31 | 37.05 |
| Support Level | $3.36 | $32.30 |
| Resistance Level | $3.65 | $38.57 |
| Average True Range (ATR) | 0.20 | 1.13 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 24.33 | 20.10 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.